Xeris Pharmaceuticals

Xeris Biopharma (NASDAQ: XERS) is a commercial stage biopharmaceutical company, commercializing therapeutics in Endocrinology, Neurology and Rare Diseases, and leveraging proprietary non-aqueous formulation platforms to develop novel ultra highly concentrated (>450mg/mL), ready-to-use, subcutaneously injectable biologics and small molecule drugs

Address

Chicago
Illinois
United States
Loading